During the past decade, Cancer and Blood Specialty Clinic conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer and Blood Specialty Clinic" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Novartis Pharmaceuticals" with 2 trials sponsored, "Cardiff Oncology" with 1 trials sponsored, "Celcuity, Inc." with 1 trials sponsored and "G1 Therapeutics, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer and Blood Specialty Clinic" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Cancer and Blood Specialty Clinic" are "Breast Cancer" (2 trials), "Neoplasm Metastasis" (2 trials), "Triple Negative Breast Cancer" (2 trials), "Abiraterone Acetate" (1 trials) and "Androgens" (1 trials). Many other conditions were trialed in "Cancer and Blood Specialty Clinic" in a lesser frequency.

Most popular intervention types in "Cancer and Blood Specialty Clinic" are "Drug" (11 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (2 trials), "Fulvestrant" (2 trials), "Abiraterone" (1 trials) and "Alpelisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cancer and Blood Specialty Clinic" are 9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer and Blood Specialty Clinic". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cancer and Blood Specialty Clinic, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cancer and Blood Specialty Clinic, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".